Department of Sciences, University of Basilicata, viale Ateneo Lucano 10, 85100, Potenza, Italy.
Center for Reproductive Medicine of "San Carlo" Hospital, via Potito Petrone, 85100, Potenza, Italy.
Metabolomics. 2019 Jan 29;15(2):19. doi: 10.1007/s11306-019-1481-x.
Several metabolomics studies have correlated follicular fluid (FF) metabolite composition with oocyte competence to fertilization, embryo development and pregnancy but there is a scarcity of research examining the metabolic effects of various gynaecological diseases.
In this study we aimed to analyze and correlate the metabolic profile of FF from women who were following in vitro fertilization (IVF) treatments with their different infertility pathologies.
We selected 53 women undergoing IVF who were affected by: tubal diseases, unexplained infertility, endometriosis, polycystic ovary syndrome (PCOS). FF of the study participants was collected at the time of oocytes retrieval. Metabolomic analysis of FF was performed by nuclear magnetic resonance (NMR) spectroscopy.
FF presents some significant differences in various infertility pathologies. Although it was not possible to discriminate between FF of control participants and women with tubal diseases and unexplained infertility, comparison of FF metabolic profile from control women with patients with endometriosis and PCOS revealed significant differences in some metabolites that can be correlated to the causes of infertility.
NMR-based metabolic profiling may be successfully applied to find diagnostic biomarkers for PCOS and endometriosis and it might be also used to predict oocyte developmental potential and subsequent outcome.
几项代谢组学研究已经将卵泡液(FF)代谢产物组成与卵母细胞受精、胚胎发育和妊娠能力相关联,但很少有研究检查各种妇科疾病的代谢影响。
在这项研究中,我们旨在分析和关联接受体外受精(IVF)治疗的女性 FF 的代谢谱及其不同的不孕病理。
我们选择了 53 名接受 IVF 治疗的女性,她们患有:输卵管疾病、不明原因的不孕、子宫内膜异位症、多囊卵巢综合征(PCOS)。研究参与者的 FF 在取卵时收集。通过核磁共振(NMR)光谱法对 FF 的代谢组学进行分析。
FF 在各种不孕病理中存在一些显著差异。虽然无法区分对照组参与者和患有输卵管疾病和不明原因不孕的女性的 FF,但与对照组女性与子宫内膜异位症和 PCOS 患者的 FF 代谢谱进行比较,发现一些代谢物存在显著差异,这些代谢物与不孕的原因相关。
基于 NMR 的代谢组学分析可成功应用于寻找 PCOS 和子宫内膜异位症的诊断生物标志物,也可用于预测卵母细胞发育潜能和随后的结果。